|
1
|
Katari V, Kanajam LSP, Kokkiligadda S,
Sharon T and Kantamaneni P: A review on causes of myocardial
infarction and its management. World J Pharmaceutical Res.
12:511–529. 2023.
|
|
2
|
Sagris M, Antonopoulos AS, Theofilis P,
Oikonomou E, Siasos G, Tsalamandris S, Antoniades C, Brilakis ES,
Kaski JC and Tousoulis D: Risk factors profile of young and older
patients with myocardial infarction. Cardiovasc Res. 118:2281–2292.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khan IA, Karim HMR, Panda CK, Ahmed G and
Nayak S: Atypical presentations of myocardial infarction: A
systematic review of case reports. Cureus. 15:e354922023.PubMed/NCBI
|
|
4
|
Camacho X, Nedkoff L, Wright FL, Nghiem N,
Buajitti E, Goldacre R, Rosella LC, Seminog O, Tan EJ, Hayes A, et
al: Relative contribution of trends in myocardial infarction event
rates and case fatality to declines in mortality: An international
comparative study of 1 95 million events in 80 4 million people in
four countries. Lancet Public Health. 7:e229–e239. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fathima SN: An update on myocardial
infarction. Curr Res Trends Med Sci Technol. 1:152021.
|
|
6
|
Dos Santos CC, Matharoo AS, Cueva EP, Amin
U, Ramos AAP, Mann NK, Maheen S, Butchireddy J, Falki VB, Itrat A,
et al: The influence of sex, age, and race on coronary artery
disease: A narrative review. Cureus. 15:e477992023.PubMed/NCBI
|
|
7
|
Radu RI, Ben Gal T, Abdelhamid M, Antohi
EL, Adamo M, Ambrosy AP, Geavlete O, Lopatin Y, Lyon A, Miro O, et
al: Antithrombotic and anticoagulation therapies in cardiogenic
shock: A critical review of the published literature. ESC Heart
Fail. 8:4717–4736. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zangrillo A, Lomivorotov VV, Pasyuga VV,
Belletti A, Gazivoda G, Monaco F, Nigro Neto C, Likhvantsev VV,
Bradic N, Lozovskiy A, et al: Effect of volatile anesthetics on
myocardial infarction after coronary artery surgery: A post hoc
analysis of a randomized trial. J Cardiothorac Vasc Anesth.
36:2454–2462. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Körner J, Albani S, Sudha Bhagavath
Eswaran V, Roehl AB, Rossetti G and Lampert A: Sodium channels and
local anesthetics-old friends with new perspectives. Front
Pharmacol. 13:8370882022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gitman M, Fettiplace MR, Weinberg GL, Neal
JM and Barrington MJ: Local anesthetic systemic toxicity: A
narrative literature review and clinical update on prevention,
diagnosis, and management. Plast Reconstr Surg. 144:783–795. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dell'Olio F, Capodiferro S, Lorusso P,
Limongelli L, Tempesta A, Massaro M, Grasso S and Favia G: Light
conscious sedation in patients with previous acute myocardial
infarction needing exodontia: An observational study. Cureus.
11:e65082019.PubMed/NCBI
|
|
12
|
Mosqueira M, Aykut G and Fink RH:
Mepivacaine reduces calcium transients in isolated murine
ventricular cardiomyocytes. BMC Anesthesiol. 20:102020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Groot-van der Mooren M, Quint S, Knobbe
I, Cronie D and van Weissenbruch M: Severe cardiorespiratory and
neurologic symptoms in a neonate due to mepivacaine intoxication.
Case Rep Pediatr. 2019:40135642019.PubMed/NCBI
|
|
14
|
Andrade A, Brennecke A, Mallat S, Brown J,
Gomez-Rivadeneira J, Czepiel N and Londrigan L: Genetic
associations between voltage-gated calcium channels and psychiatric
disorders. Int J Mol Sci. 20:35372019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gilbert G, Demydenko K, Dries E, Puertas
RD, Jin X, Sipido K and Roderick HL: Calcium signaling in
cardiomyocyte function. Cold Spring Harb Perspect Biol.
12:a0354282020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shah K, Seeley S, Schulz C, Fisher J and
Gururaja Rao S: Calcium channels in the heart: Disease states and
drugs. Cells. 11:9432022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Erdogmus S, Concepcion AR, Yamashita M,
Sidhu I, Tao AY, Li W, Rocha PP, Huang B, Garippa R, Lee B, et al:
Cavβ1 regulates T cell expansion and apoptosis independently of
voltage-gated Ca2+ channel function. Nat Commun. 13:20332022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xuan L, Zhu Y, Liu Y, Yang H, Wang S, Li
Q, Yang C, Jiao L, Zhang Y, Yang B and Sun L: Up-regulation of
miR-195 contributes to cardiac hypertrophy-induced arrhythmia by
targeting calcium and potassium channels. J Cell Mol Med.
24:7991–8005. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang
F, Zhang Y, Shan H, Luo X, Bai Y, et al: MicroRNA-328 contributes
to adverse electrical remodeling in atrial fibrillation.
Circulation. 122:2378–2387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Couch LS, Fiedler J, Chick G, Clayton R,
Dries E, Wienecke LM, Fu L, Fourre J, Pandey P, Derda AA, et al:
Circulating microRNAs predispose to takotsubo syndrome following
high-dose adrenaline exposure. Cardiovasc Res. 118:1758–1770. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scarparo HC, Maia RN, Filho ED, Soares E,
Costa F, Fonteles C, Bezerra TP, Ribeiro TR and Romero NR: Plasma
mepivacaine concentrations in patients undergoing third molar
surgery. Aust Dent J. 61:446–454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Q and Zhang L: MicroRNA-183-5p
protects human derived cell line SH-SY5Y cells from
mepivacaine-induced injury. Bioengineered. 12:3177–3187. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng L, Zhang H, Wu F, Liu Z, Cheng Y and
Wang C: Role of Nrf2 and its activators in cardiocerebral vascular
disease. Oxid Med Cell Longev. 2020:46839432020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao E, Xie H and Zhang Y: Predicting
diagnostic gene biomarkers associated with immune infiltration in
patients with acute myocardial infarction. Front Cardiovasc Med.
7:5868712020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Q, Wang L, Wang S, Cheng H, Xu L,
Pei G, Wang Y, Fu C, Jiang Y, He C and Wei Q: Signaling pathways
and targeted therapy for myocardial infarction. Signal Transduct
Target Ther. 7:782022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paolisso P, Foà A, Bergamaschi L, Donati
F, Fabrizio M, Chiti C, Angeli F, Toniolo S, Stefanizzi A,
Armillotta M, et al: Hyperglycemia, inflammatory response and
infarct size in obstructive acute myocardial infarction and MINOCA.
Cardiovasc Diabetol. 20:332021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao X, Ren Y, Ren H, Wu Y, Liu X, Chen H
and Ying C: The mechanism of myocardial fibrosis is ameliorated by
myocardial infarction-associated transcript through the PI3K/Akt
signaling pathway to relieve heart failure. J Int Med Res. Jul
18–2021. View Article : Google Scholar
|
|
29
|
Burgos EG, García-García LL,
Gómez-Serranillos MP and Oliver FG: Local Anesthetics. Adv
Neuropharmacol. 351–388. 2020. View Article : Google Scholar
|
|
30
|
Lottinger C: Local anesthetics in
dentistry. Evidence-Based Oral Surgery. Springer; London: pp.
129–150. 2019
|
|
31
|
Ozbay S, Ayan M and Karcioglu O: Local
anesthetics, clinical uses, and toxicity: Recognition and
management. Curr Pharm Des. 29:1414–1420. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aladağ N, Asoğlu R, Ozdemir M, Asoğlu E,
Derin AR, Demir C and Demir H: Oxidants and antioxidants in
myocardial infarction (MI): Investigation of ischemia modified
albumin, malondialdehyde, superoxide dismutase and catalase in
individuals diagnosed with ST elevated myocardial infarction
(STEMI) and non-STEMI (NSTEMI). J Med Biochem. 40:2862021.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mitsis A, Kadoglou NP, Lambadiari V,
Alexiou S, Theodoropoulos KC, Avraamides P and Kassimis G:
Prognostic role of inflammatory cytokines and novel adipokines in
acute myocardial infarction: An updated and comprehensive review.
Cytokine. 153:1558482022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H and Dhalla NS: The role of
pro-inflammatory cytokines in the Pathogenesis of Cardiovascular
Disease. Int J Mol Sci. 25:10822024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shao L, Shen Y, Ren C, Kobayashi S,
Asahara T and Yang J: Inflammation in myocardial infarction: Roles
of mesenchymal stem cells and their secretome. Cell Death Discov.
8:4522022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tuluc P, Theiner T, Jacobo-Piqueras N and
Geisler SM: Role of high Voltage-Gated Ca2+ Channel subunits in
pancreatic β-cell insulin release. From structure to function.
Cells. 10:20042021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang S, Yan F, Luan F, Chai Y, Li N, Wang
YW, Chen ZL, Xu DQ and Tang YP: The pathological mechanisms and
potential therapeutic drugs for myocardial ischemia reperfusion
injury. Phytomedicine. 129:1556492024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang D, Wu H, Liu D, Li Y and Zhou G:
Research progress on the mechanism and treatment of inflammatory
response in myocardial Ischemia-reperfusion injury. Heart Surg
Forum. 25:E462–E468. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Algoet M, Janssens S, Himmelreich U, Gsell
W, Pusovnik M, Van den Eynde J and Oosterlinck W: Myocardial
ischemia-reperfusion injury and the influence of inflammation.
Trends Cardiovasc Med. 33:357–366. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li YW, Liu Y, Luo SZ, Huang XJ, Shen Y,
Wang WS and Lang ZC: The significance of calcium ions in cerebral
ischemia-reperfusion injury: Mechanisms and intervention
strategies. Front Mol Biosci. 12:15857582025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
He J, Liu D, Zhao L, Zhou D, Rong J, Zhang
L and Xia Z: Myocardial ischemia/reperfusion injury: Mechanisms of
injury and implications for management. Exp Ther Med. 23:4302022.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Trujillo-Rangel WÁ, García-Valdés L,
Méndez-del Villar M, Castañeda-Arellano R, Totsuka-Sutto SE and
García-Benavides L: Therapeutic targets for regulating oxidative
damage induced by ischemia-reperfusion injury: A study from a
pharmacological perspective. Oxid Med Cell Longev.
2022:86243182022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vairamani K, Prasad V, Wang Y, Huang W,
Chen Y, Medvedovic M, Lorenz JN and Shull GE: NBCe1
Na+-HCO3-cotransporter ablation causes reduced apoptosis following
cardiac ischemia-reperfusion injury in vivo. World J Cardiol.
10:972018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang Y, Zhang X, Wen Y, Li S, Lu X, Xu R
and Li C: Endoplasmic reticulum-mitochondria contacts: A potential
therapy target for cardiovascular remodeling-associated diseases.
Front Cell Dev Biol. 9:7749892021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Luan Y, Luan Y, Yuan R-X, Feng Q, Chen X
and Yang Y: Structure and function of mitochondria-associated
endoplasmic reticulum membranes (MAMs) and their role in
cardiovascular diseases. Oxid Med Cell Longev. 2021:45788092021.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li W, Cao T, Luo C, Cai J, Zhou X, Xiao X
and Liu S: Crosstalk between ER stress, NLRP3 inflammasome, and
inflammation. Appl Microbiol Biotechnol. 104:6129–6140. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Saha S, Buttari B, Panieri E, Profumo E
and Saso L: An overview of Nrf2 signaling pathway and its role in
inflammation. Molecules. 25:54742020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang L and Hauenstein AV: The NLRP3
inflammasome: Mechanism of action, role in disease and therapies.
Mol Aspects Med. 76:1008892020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tastan B, Arioz BI and Genc S: Targeting
NLRP3 inflammasome with Nrf2 inducers in central nervous system
disorders. Front Immunol. 13:8657722022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nie Q, Zhang J, He B, Wang F, Sun M, Wang
C, Sun W, Guo J, Wen J and Liu P: A novel mechanism of protection
against isoproterenol-induced cardiac inflammation via regulation
of the SIRT1/NRF2 signaling pathway with a natural SIRT1 agonist.
Eur J Pharmacol. 886:1733982020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mauro AG, Bonaventura A, Mezzaroma E,
Quader M and Toldo S: NLRP3 inflammasome in acute myocardial
infarction. J Cardiovasc Pharmacol. 74:175–187. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shen Y, Liu X, Shi J and Wu X: Involvement
of Nrf2 in myocardial ischemia and reperfusion injury. Int J Biol
Macromol. 125:496–502. 2019. View Article : Google Scholar : PubMed/NCBI
|
